Fredun Pharmaceuticals Ltd vs Mono Pharmacare Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Jun 14, 2026

Key Highlights

The Latest Trading Price of Fredun Pharmaceuticals Ltd is ₹ 2310 as of 12 Jun 15:30 . The P/E Ratio of Fredun Pharmaceuticals Ltd is 16 as of March 2025 .The P/E Ratio of Mono Pharmacare Ltd is 13.2 as of March 2025 . The Market Cap of Fredun Pharmaceuticals Ltd is ₹ 315.67 crore as of March 2025 .The Market Cap of Mono Pharmacare Ltd is ₹ 40.81 crore as of March 2025 . The revenue of Fredun Pharmaceuticals Ltd for the Mar '26 is ₹ 213.06 crore as compare to the Dec '25 revenue of ₹ 160.92 crore. This represent the growth of 32.4% The revenue of Mono Pharmacare Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Fredun Pharmaceuticals Ltd for the Mar '26 is ₹ 28.88 crore as compare to the Dec '25 ebitda of ₹ 26.34 crore. This represent the growth of 9.64% The ebitda of Mono Pharmacare Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Fredun Pharmaceuticals Ltd changed from ₹ 13.74 crore to ₹ 10.78 crore over 6 quarters. This represents a CAGR of -14.93% The net profit of Mono Pharmacare Ltd changed from ₹ 0 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of 0.0% The Dividend Payout of Fredun Pharmaceuticals Ltd changed from 13.9 % on March 2021 to 1.59 % on March 2025 . This represents a CAGR of -35.18% over 5 yearsThe Dividend Payout of Mono Pharmacare Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Fredun Pharmaceuticals Ltd

Incorporated in 1987 as a private limited company, Fredun Pharmaceuticals Limited (FPL) was converted into a public limited company in Mar.'94.
The Company was promoted by Nariman Medhora and Daulat N Medhora.
The promoters initially established D N Pharma, a proprietary firm, for the manufacture and export of pharmaceutical formulations.
Since 1993, D N Pharma's operations were phased out in order to switch over the business to FPL. The Company is well diversified in the business ranging from Formulations to Diagnostics to Consultancy.
The Company has an unique range of products, from niche formulations , anti-diabetics to the latest antiretroviral and anti - Hypertensive products.

About Mono Pharmacare Ltd

Mono Pharmacare Limited was originally formed as a Partnership Firm in the name and style of 'M/s.
Mono Chemist' through Partnership Deed dated May 06, 1994.
The Partnership Firm was then converted into Public Limited company in the name of Mono Pharmacare Limited vide Certificate of Incorporation dated October 17, 2022, was issued by the Registrar of Companies, Ahmedabad.
The Company is engaged in the business of marketing and distribution of pharmaceutical products. The product portfolio comprises of a wide range of drugs like Antibiotics, Antifungal, Anti CoughCold & Anti-allergic, Antacid and Antiemetics, Analgesics and Antipyretics, Nutraceuticals, Skincare, Antiseptic, Cardiac and Diabetic & Cosmetics etc. getting products manufactured through contract manufacturing. Supal Distributors LLP, a Partnership Firm, was incorporated on November 24, 2016, with the Promoters of Company, Panilam Lakhatariya and Supal Lakhatariya, being the Original Partners.

FAQs for the comparison of Fredun Pharmaceuticals Ltd and Mono Pharmacare Ltd

Which company has a larger market capitalization, Fredun Pharmaceuticals Ltd or Mono Pharmacare Ltd?

Market cap of Fredun Pharmaceuticals Ltd is 1,273 Cr while Market cap of Mono Pharmacare Ltd is 20 Cr

What are the key factors driving the stock performance of Fredun Pharmaceuticals Ltd and Mono Pharmacare Ltd?

The stock performance of Fredun Pharmaceuticals Ltd and Mono Pharmacare Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Fredun Pharmaceuticals Ltd and Mono Pharmacare Ltd?

As of June 14, 2026, the Fredun Pharmaceuticals Ltd stock price is INR ₹2310.75. On the other hand, Mono Pharmacare Ltd stock price is INR ₹11.65.

How do dividend payouts of Fredun Pharmaceuticals Ltd and Mono Pharmacare Ltd compare?

To compare the dividend payouts of Fredun Pharmaceuticals Ltd and Mono Pharmacare Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.